TY - JOUR
T1 - Management of placenta accreta spectrum disorders in COVID 19 patients
AU - Aryananda, Rozi Aditya
AU - Nieto-Calvache, Albaro José
AU - Cininta, Nareswari Imanadha
AU - Bachtiar, Citra Aulia
AU - Wardhana, Manggala Pasca
AU - Vergara Galliadi, Lina Maria
AU - Messa Bryon, Adriana
AU - Burgos Luna, Juan Manuel
N1 - Publisher Copyright:
© 2021 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2022
Y1 - 2022
N2 - Introduction: The COVID-19 pandemic has made it difficult to respond to demands in maternal health around the world. Placenta accreta spectrum (PAS) is one of the most severe obstetric conditions and usually requires the use of multiple health resources We describe the clinical results of the management of PAS patients during the COVID-19 pandemic and analyze how the pandemic may affect the functioning of a PAS team. Methodology: This was a descriptive, retrospective study including all patients treated for PAS in two low- to middle-income country reference hospitals between January 2020 and March 2021. The clinical results of patients with SARS-CoV-2 infection during PAS surgery (Group 1) were compared with those of PAS patients without SARS-CoV-2 infection (Group 2). Results: One hundred forty-five patients undergoing surgery for PAS were included. Group 1 patients (11 cases) showed a longer operative time (250 min, IQR 200–300) and a higher frequency of intra- or postoperative complications (54.5%) than group 2 patients (180 min [IQR 125–240], and 17.9%). Conclusion: Placenta accreta spectrum patients undergoing surgery during acute SARS-CoV-2 infection have a higher frequency of postoperative complications. PAS teams must prepare to modify their management protocols to minimize risks for patients and healthcare personnel.
AB - Introduction: The COVID-19 pandemic has made it difficult to respond to demands in maternal health around the world. Placenta accreta spectrum (PAS) is one of the most severe obstetric conditions and usually requires the use of multiple health resources We describe the clinical results of the management of PAS patients during the COVID-19 pandemic and analyze how the pandemic may affect the functioning of a PAS team. Methodology: This was a descriptive, retrospective study including all patients treated for PAS in two low- to middle-income country reference hospitals between January 2020 and March 2021. The clinical results of patients with SARS-CoV-2 infection during PAS surgery (Group 1) were compared with those of PAS patients without SARS-CoV-2 infection (Group 2). Results: One hundred forty-five patients undergoing surgery for PAS were included. Group 1 patients (11 cases) showed a longer operative time (250 min, IQR 200–300) and a higher frequency of intra- or postoperative complications (54.5%) than group 2 patients (180 min [IQR 125–240], and 17.9%). Conclusion: Placenta accreta spectrum patients undergoing surgery during acute SARS-CoV-2 infection have a higher frequency of postoperative complications. PAS teams must prepare to modify their management protocols to minimize risks for patients and healthcare personnel.
KW - COVID-19
KW - Placenta accreta
KW - SARS CoV-2
KW - biosafety
KW - personal protective equipment
KW - postoperative complications
UR - http://www.scopus.com/inward/record.url?scp=85119864669&partnerID=8YFLogxK
U2 - 10.1080/14767058.2021.2005567
DO - 10.1080/14767058.2021.2005567
M3 - Article
AN - SCOPUS:85119864669
SN - 1476-7058
VL - 35
SP - 8844
EP - 8847
JO - Journal of Maternal-Fetal and Neonatal Medicine
JF - Journal of Maternal-Fetal and Neonatal Medicine
IS - 25
ER -
